Trial Profile
The effect of eldecalcitol on bone mineral density and bone markers for osteoporotic patients with type 2 diabetes. Open label multicenter study.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 20 Jul 2012 New trial record